Trial intelligence / Profile preview

Intratracheal Budesonide to Prevent Bronchopulmonary Dysplasia in Preterm Neonates with RDS

NCT07725575Phase 4Completed

Sponsor
Universitas Indonesia
Start
Nov 2024
Primary completion
Apr 2025
Countries
1
01

Overview

A Phase 4 trial of budesonide in bronchopulmonary dysplasia (BPD), sponsored by Universitas Indonesia. Started Nov 2024; status: completed.

02

Drugs

budesonide
03

Conditions

bronchopulmonary dysplasia (BPD)

Beyond the preview

Go deeper on NCT07725575.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07725575.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call